alexa Abstract | Pharmacogenetics and Molecular study on BCR/ABL Inhibitors connected with Chronic Myeloid Leukemia; Genotype variability polymorphism among Babylon population

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


Our study aimed to investigate the association between multidrug resistance BCR/ABL1 gene polymorphisms associated with chronic myeloid leukemia (CML). The BCR/ABL1 oncogene contributes to the progress of CML clones. BCR/ABL played significant roles in the pathogenesis in CML. Expression of BCR-ABL in patients were 88.9%, while in control was 6.7%

To read the full article Peer-reviewed Article PDF image

Author(s): Israa Hussein Noor Hassan Ali Hussein AlMarzoqi and Zainab Wahab Maroof


BCR/ABL, CML, Genotype, Pharmacogenetics, Myeloid Leukemia

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version